Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination product containing **esomeprazole** (a proton pump inhibitor or PPI) and **amoxicillin** and **clarithromycin** (antibiotics). It is designed for the eradication of *Helicobacter pylori* (H. pylori) infection. Esomeprazole reduces stomach acid, facilitating the healing of ulcers and improving antibiotic efficacy. Amoxicillin and clarithromycin are used to kill the H. pylori bacteria.
## Primary Indications
* Treatment of *Helicobacter pylori* infection in patients with peptic ulcer disease.
## Adult Dosing
The typical adult regimen is:
* **Esomeprazole:** 20 mg orally twice daily
* **Amoxicillin:** 1 gram orally twice daily
* **Clarithromycin:** 500 mg orally twice daily
This regimen is usually prescribed for **10 to 14 days**. Specific duration may vary based on local guidelines or physician discretion.
## Pediatric Dosing
Dosing for pediatric patients is not well-established for this specific combination product and will depend on the individual components. Pediatric dosing for H. pylori eradication with PPIs and antibiotics is complex and should be determined by a specialist, considering age, weight, and renal/hepatic function.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment is typically required for esomeprazole. Amoxicillin and clarithromycin may require dose adjustment in severe renal impairment; consult specific prescribing information.
* **Hepatic Impairment:** For esomeprazole, reduce the dose in severe hepatic impairment. For clarithromycin, reduce the dose in moderate to severe hepatic impairment. Amoxicillin typically does not require dose adjustment.
## Contraindications
* Hypersensitivity to esomeprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of allergic reactions to penicillins or cephalosporins.
* History of cholestatic jaundice/hepatic dysfunction associated with prior macrolide exposure.
* Concomitant use with colchicine, ergotamine, or pimozide due to potential for serious drug interactions with clarithromycin.
* Electrolyte abnormalities, particularly hypokalemia, hypomagnesemia, and hypocalcemia, as these can increase the risk of QT prolongation with clarithromycin.
## Adverse Effects
Common adverse effects include:
* **GI:** Diarrhea, nausea, vomiting, abdominal pain, taste disturbances (metallic taste with clarithromycin).
* **Headache**
* **Rash**
* **QT prolongation** (associated with clarithromycin)
* **Clostridioides difficile-associated diarrhea**
## Key Drug Interactions
* **Clarithromycin:** Can inhibit CYP3A4, leading to increased levels of various drugs (e.g., statins, anticoagulants, calcium channel blockers, certain immunosuppressants). Monitor closely and consider dose adjustments or alternatives.
* **Esomeprazole:** Can decrease the absorption of drugs that require acidic gastric pH (e.g., ketoconazole, iron salts, vitamin B12).
* **Amoxicillin:** May decrease the efficacy of oral contraceptives.
## Monitoring
* **Efficacy:** Assess H. pylori eradication status (e.g., stool antigen test, urea breath test) approximately 4-8 weeks after completion of therapy.
* **Adverse Effects:** Monitor for GI disturbances, signs of hypersensitivity, and potential electrolyte imbalances.
* **QT Interval:** Consider ECG monitoring if risk factors for QT prolongation are present, especially with clarithromycin.
## Clinical Pearls
* Ensure the full course of therapy is completed to maximize eradication rates and minimize resistance development.
* Patients with penicillin allergy should not receive amoxicillin.
* Counsel patients on potential side effects, including diarrhea, and advise them to report severe or persistent symptoms.
* Refrigerate liquid amoxicillin suspensions after reconstitution.
***
**Disclaimer:** This information is intended for clinical decision-making and does not replace the official prescribing information or professional judgment. Always verify current product information and guidelines before prescribing.
